

Peptide · P41
PT-141
PT-141 is the research name for bremelanotide, a cyclic peptide that activates several melanocortin receptor subtypes.
For laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent disease.
What researchers study
PT-141 in context
It is used to study central melanocortin signaling, particularly pathways involving MC4 receptors in the central nervous system.
Read the full research profileReference profile
Identity & specifications
Reference identities are provided to clarify nomenclature. Salts, counterions, hydration, and analytical conventions can affect reported formula and mass. Consult the linked public record and your own laboratory methods.
Product questions
Before adding
to your bag.
What does the listed purity mean?
It is the catalog specification used to describe the intended material standard.
Is this material intended for human or veterinary use?
No. It is sold solely for lawful laboratory research and may not be consumed, self-administered, compounded for patient use, or used in humans or animals.
Does Apex provide preparation or dosing instructions?
No. Apex does not provide reconstitution, dosing, administration, treatment, or personal-use guidance.
Scientific context
Use evidence with precision.
What this profile does
It identifies the material and supplies neutral catalog details useful for research planning and recordkeeping.
What it does not do
It does not establish safety, efficacy, clinical suitability, or an expected human outcome. Preclinical observations cannot be presented as consumer benefits.


